VIDPREVTYN BETA, solution et émulsion pour émulsion injectable. Vaccin contre la COVID-19 (recombinant avec adjuvant) — 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL- 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL (100 doses),

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930264157
  • CIP7 3026415
  • CIS 67734275
  • Registration number EU/1/21/1580

What the source publishes

Holder
SANOFI PASTEUR
Active ingredients
PROTÉINE SPIKE RECOMBINANTE DU SARS-COV-2 - SOUCHE B.1.351
Form
solution et émulsion pour émulsion injectable
Package
10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL- 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL (100 doses),
Routes
intramusculaire
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2022-11-10
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930264157
{
  "cis": "67734275",
  "cip7": "3026415",
  "form": "solution et  émulsion pour émulsion injectable",
  "name": "VIDPREVTYN BETA, solution et émulsion pour émulsion injectable. Vaccin contre la COVID-19 (recombinant avec adjuvant) — 10 flacon(s) multidose(s) de 10 doses  en verre de 2,5 mL- 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL (100 doses),",
  "cip13": "3400930264157",
  "holder": "SANOFI PASTEUR",
  "routes": [
    "intramusculaire"
  ],
  "holders": [
    "SANOFI PASTEUR"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2022-11-10",
  "compositions": [
    {
      "name": "PROTÉINE SPIKE RECOMBINANTE DU SARS-COV-2 - SOUCHE B.1.351",
      "nature": "SA",
      "strength": "5 microgrammes",
      "linkageNumber": "1",
      "substanceCode": "52633",
      "dosageReference": "une dose de 0,5 mL",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "VIDPREVTYN BETA, solution et émulsion pour émulsion injectable. Vaccin contre la COVID-19 (recombinant avec adjuvant)",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "10 flacon(s) multidose(s) de 10 doses  en verre de 2,5 mL- 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL (100 doses),",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2023-03-31",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "PROTÉINE SPIKE RECOMBINANTE DU SARS-COV-2 - SOUCHE B.1.351"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": "EU/1/21/1580",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930264157"